Immunovant, Inc. (IMVT)
Data as of , from SEC Form 4 filings.
See up to 3 months of IMVT. The 7-day demo opens the 1M and 3M ranges and puts IMVT on your watchlist.
Start 7-day demoLatest IMVT insider trades
Jay S. Stout - OfficerOpen-market sale$71K
About Immunovant, Inc. (IMVT)
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
- DURHAM, NC
- 315
- 2019
- XNAS
IMVT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 29,440 | $1.09M |
| Option exercise | 6 | 190,374 | |
| Derivative transaction | 1 | 85,886 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IMVT insider transactions (Form 4)
1775 Form 4 filings on record, the earliest from Oct 11, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Atul Pande - Director | Open-market sale | Common Stock | 7,750 | $28.54 | $221K | |
| William L. Macias - Officer | Open-market sale | Common Stock | 3,353 | $25.45 | $85K | |
| Eva Renee Barnett - Officer | Open-market sale | Common Stock | 4,174 | $25.45 | $106K | |
| Peter Salzmann - Officer | Open-market sale | Common Stock | 16,692 | $25.45 | $425K | |
| Mark S. Levine - Officer | Open-market sale | Common Stock | 3,650 | $25.45 | $93K | |
| Melanie Gloria - Officer | Grant or award | Common Stock | 109,956 | $0.00 | - | |
| Melanie Gloria - Officer | Grant or award | Stock Option (right to buy) | 137,446 | $0.00 | - | |
 Michael Geffner - Officer | Open-market sale | Common Stock | 3,189 | $29.53 | $94K | |
| Jay S. Stout - Officer | Open-market sale | Common Stock | 2,740 | $29.53 | $81K | |
| Mark S. Levine - Officer | Open-market sale | Common Stock | 4,361 | $29.53 | $129K | |
| Peter Salzmann - Officer | Open-market sale | Common Stock | 9,095 | $28.79 | $262K | |
| William L. Macias - Officer | Open-market sale | Common Stock | 2,627 | $28.79 | $76K | |
| William L. Macias - Officer | Open-market sale | Common Stock | 561 | $28.79 | $16K | |
| Eva Renee Barnett - Officer | Open-market sale | Common Stock | 3,271 | $28.79 | $94K | |
| Mark S. Levine - Officer | Open-market sale | Common Stock | 2,860 | $28.79 | $82K | |
| Eva Renee Barnett - Officer | Open-market sale | Common Stock | 5,162 | $29.56 | $153K | |
| Peter Salzmann - Officer | Open-market sale | Common Stock | 4,460 | $29.56 | $132K |
Recent IMVT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
IMVT insider trading FAQ
What is the latest insider trade for IMVT?
Immunovant, Inc. (IMVT) had 10 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for IMVT runs to 75 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMVT stock?
No insider purchases of IMVT were filed in the last 90 days.
How many insiders are selling IMVT stock?
11 insider sales of IMVT were filed in the last 90 days, totaling $1.09M.
Where can I see IMVT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMVT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jay S. Stout view on EDGAR
- - Tuyl Christopher van view on EDGAR
- - Melanie Gloria view on EDGAR
- - Eric Venker view on EDGAR
- - Tuyl Christopher van view on EDGAR
- - Atul Pande view on EDGAR
- - Melanie Gloria view on EDGAR
- - Atul Pande view on EDGAR
- - Tiago Girao view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IMVT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMVT with a 7-day demo
- IMVT on your watchlist
- Every IMVT Form 4 filing on record
- Up to 3 months of IMVT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
